Does Dengue Need Hospital Care? When Fluids and Monitoring Move From the Clinic to a Ward

The thermometer finally reads normal on the fourth morning, and the relief in the room is almost physical. Then the nurse at the clinic looks at the lab slip, asks how many times the vomiting happened overnight, presses gently below the ribs on the right, and says the words nobody wanted: “I think we should admit you today.” For families who have watched someone sweat through three days of fever, this feels backwards. The fever is gone. Why now?

That question sits at the heart of dengue hospital or outpatient treatment. Dengue is unusual among common infections because the most dangerous window often opens as the fever closes, and because the decision to move from a clinic chair to a ward bed rests less on how sick someone looks and more on a handful of warning signs and two or three numbers on a blood count.

This explainer walks through what happens inside the body, how clinicians sort patients into those who can safely stay home and those who need a drip and a monitor, what a ward stay actually involves, and where popular beliefs about platelets and “the best hospital” go wrong.

What actually happens in the body during dengue

Dengue is a viral infection carried between people by Aedes mosquitoes, most often Aedes aegypti, a daytime biter that thrives around homes. According to the World Health Organization, the virus comes in four closely related types, called serotypes, and roughly half the world’s population now lives in areas where it circulates, with an estimated 100 to 400 million infections a year. Most of those infections cause no symptoms or a mild illness that passes on its own.

When symptoms do appear, they arrive 4 to 10 days after the bite and the fever typically lasts 2 to 7 days, per WHO. Clinicians describe the illness in three phases. The febrile phase brings high temperature, headache, pain behind the eyes, muscle and joint aches, and sometimes a rash. The critical phase begins as the fever drops. The recovery phase follows, often with a second rash, itching and a tiredness that lingers for days.

The critical phase is where the real risk hides. In a minority of people, the virus and the immune response make the walls of tiny blood vessels leaky, so that the watery part of blood, the plasma, seeps out into tissues and body cavities. Doctors call this plasma leakage. When enough plasma leaves the circulation, blood pressure falls and organs are starved of flow, a state called shock. At the same time, the platelet count, a measure of the small cell fragments that help blood clot, often falls, which is why bleeding from the gums or nose can appear.

Nothing in the standard toolkit stops the virus itself. What medicine can do is replace lost fluid at the right pace, watch closely for the turn toward leakage, and act before shock takes hold. That single fact explains almost every decision about home versus hospital.

Dengue hospital or outpatient treatment: how clinicians decide

The WHO’s clinical guidance, which the CDC follows in its clinician material, sorts people with suspected dengue into three broad groups at each visit. The labels are simple, and it helps to know them because they are the language your care team is using behind the desk.

Group A describes people who can be managed at home. They tolerate oral fluids, pass urine at least every six hours or so, have no warning signs and no conditions that raise their baseline risk. Group B covers people with warning signs, or with circumstances that make home care unsafe: pregnancy, infancy, older age, diabetes, kidney disease, heart disease, obesity, or simply living alone far from a clinic. Group C is severe dengue, meaning established plasma leakage with shock or fluid in the lungs, significant bleeding, or organ involvement such as the liver, heart or brain. Group C needs emergency treatment.

Two things about this system matter for patients. First, the groups are not fixed labels. A person assessed as Group A on day two can move to Group B on day four, which is why outpatient care almost always includes a daily review rather than a single visit and a wave goodbye. Second, the assessment weighs risk, not just present symptoms. Someone who feels reasonably well but is 34 weeks pregnant, or who has a rising hematocrit on a repeat blood test, may be admitted for observation even without a dramatic decline.

The threshold for admission also shifts with circumstances. During a large outbreak, ward beds fill and clinicians may lean harder on structured outpatient follow-up for low-risk adults. In a setting with few beds and long distances, a doctor may admit a borderline patient precisely because a return trip at 2 a.m. would be impossible. Neither approach is wrong; both are attempts to keep the person inside a safe watching distance during the critical phase.

What outpatient dengue management looks like day to day

Home care sounds passive, but in dengue it is a job with a checklist. The CDC’s guidance for patients rests on three pillars: rest, plenty of fluids and fever control with acetaminophen, the generic name for the common over-the-counter fever reducer, taken only as directed by the clinician. Aspirin and non-steroidal anti-inflammatory drugs such as ibuprofen are avoided because they interfere with platelet function and can worsen bleeding.

Fluids deserve real attention. Water is fine, but oral rehydration solution, soups, and diluted juices add salts and sugar that help the body hold on to what it drinks. The practical goal is regular urination of a reasonably pale colour. Someone who is drinking but vomiting most of it back up is not actually hydrating, and that distinction is one of the first things a clinician will ask about at review.

Monitoring is the second half of the job. In many services, an outpatient with dengue is asked to return every day, or at least on the day the fever breaks and the day after, for a brief examination and a complete blood count. The count tracks the platelet number and the hematocrit, the proportion of blood made up of red cells. A hematocrit that climbs while platelets fall is the fingerprint of plasma leakage, and the CDC’s clinical guidance flags a rise of 20 percent or more above baseline as a marker of hemoconcentration. Catching that trend early is the whole point of coming back.

A household member matters, too. Guidance from the CDC and WHO assumes an adult is at home who can encourage drinking, notice a change in alertness, and get the patient to care quickly. Where that is not possible, admission becomes more likely, not because the illness is worse but because the safety net is thinner.

Dengue warning signs that move care from clinic to ward

The phrase “warning signs” has a specific meaning in dengue. It refers to a short list of findings that, in the WHO scheme, mark the move from Group A to Group B and usually trigger admission or, at minimum, intravenous fluids and close observation. They are not proof that severe dengue has arrived; they are the early tremors that often precede it.

The CDC and WHO list them as: severe abdominal pain or tenderness; persistent vomiting, which the CDC frames as at least three times in 24 hours; bleeding from the nose or gums, or blood in vomit or stool; unusual drowsiness, restlessness or irritability; rapid breathing; clinical signs of fluid accumulation, such as a swollen abdomen; an enlarged, tender liver on examination; and, on blood tests, a rising hematocrit alongside a rapidly falling platelet count.

Why do these particular things matter? Abdominal pain and liver tenderness often reflect fluid collecting around the liver and gut as plasma leaks. Vomiting that will not stop means oral hydration has failed, which is the main reason a drip becomes necessary. Drowsiness or restlessness can be an early sign that the brain is not receiving enough blood flow. Bleeding signals both low platelets and fragile vessels. Each item on the list is, in effect, a window onto the same underlying process.

The WHO fact sheet notes that warning signs most often appear in the 24 to 48 hours after the fever settles. That timing is why an experienced clinician will often say, “Come back tomorrow even if you feel better,” and mean it literally. Feeling better is common on the first afebrile day. It is also the moment when the temperature chart stops being useful and the examination and blood count take over as the real guides.

Who is usually admitted, and who is usually asked to recover at home

Two people can have identical fevers and identical lab results and still receive different advice, because admission decisions weigh the person as well as the illness. Guidance from the WHO and CDC identifies several groups for whom the margin for error is smaller and a ward bed is more often offered early.

Pregnant women are one such group. Plasma leakage is harder to detect against the background changes of pregnancy, and both mother and baby are affected by low blood pressure. Infants and very young children can slip into shock quickly and cannot describe abdominal pain or dizziness. Older adults and people with chronic conditions, especially diabetes, kidney disease, heart failure or obesity, tolerate fluid shifts poorly and are harder to rehydrate safely without monitoring. People on anticoagulants or with bleeding disorders carry added bleeding risk when platelets fall.

Social circumstances count as much as medical ones. Living alone, being far from a health facility, lacking transport at night or having no one at home who can watch for a change in alertness are all recognized reasons to admit someone whose bloods might otherwise permit home care.

Who is usually asked to stay home? Otherwise healthy older children and adults in the febrile phase, drinking well, passing urine regularly, with no warning signs, stable hematocrit and a platelet count that is not falling steeply. For this group, the evidence base and guideline consensus favour structured outpatient care with daily review, because a hospital bed offers little that the home cannot, provided the monitoring is real.

One caution belongs here. “Asked to wait” never means “told not to return.” Outpatient dengue care is a conditional plan. If the condition changes, so does the plan, and clinicians expect and welcome the phone call.

Home, ward or intensive care: a side-by-side summary

The table below distils WHO and CDC guidance into the three settings most people encounter. It is a map of what typically happens, not a tool for self-triage; the sorting is done by a clinician at each review.

Feature	Home (Group A)	Ward (Group B)	Intensive or emergency care (Group C)
Who	No warning signs, drinking well, urinating regularly, no high-risk condition, someone at home to watch	Warning signs present, or pregnancy, infancy, older age, chronic illness, or unsafe home situation	Established severe dengue: shock, fluid in lungs, significant bleeding or organ involvement
Fluids	Oral: water, oral rehydration solution, soups, diluted juice	Intravenous fluids, adjusted to hematocrit and vital signs	Rapid intravenous fluids, sometimes blood products
Monitoring	Daily clinic review and blood count, especially around the day fever breaks	Vital signs several times a day, urine output, repeat blood counts	Continuous monitoring, frequent bloods, organ support if needed
Fever control	Acetaminophen as directed; avoid aspirin and NSAIDs	Same	Same
Typical duration	Illness 2–7 days (WHO); reviews continue through critical phase	Through the 24–48 hour critical phase (WHO) and until stable	Until shock resolves and organ function recovers; set by the team

Notice how little changes in the medicines column. There is no drug that works on the ward and not at home. What changes is the route of fluid, the frequency of observation and the speed with which a clinician can react. That is why the decision to admit is often described as buying vigilance rather than buying treatment, and why a well-supported patient at home with daily reviews can be as safe as a low-risk patient on a busy ward.

What happens on the ward: fluids and monitoring explained

A dengue ward stay looks quiet from the corridor, and that stillness disguises how much measuring is going on. The central task is to give intravenous fluid at a rate that matches how fast plasma is leaking, then to slow or stop it as the leak seals over. Too little fluid and blood pressure falls; too much, especially once the vessels tighten again in recovery, and fluid pools in the lungs. Getting this balance right is the skill that WHO and CDC clinical guidance spends most of its pages on.

Nurses record pulse, blood pressure, breathing rate and temperature several times a day, more often if anything wobbles. They track urine output, sometimes by asking the patient to use a measuring jug, because falling urine is one of the earliest signs that the circulation is under strain. The pulse pressure, the gap between the top and bottom blood pressure numbers, is watched closely; a narrowing gap is a classic early clue to shock in dengue.

Blood is drawn once or twice a day for a complete blood count. The hematocrit acts as a proxy for plasma volume: as plasma leaks out, the remaining blood becomes more concentrated and the number climbs. Doctors adjust the drip against that trend rather than against the platelet count alone.

Platelet transfusion is not routine. Guidelines reserve it for significant bleeding, not for a low number on its own, because transfused platelets are rapidly consumed in dengue and carry their own risks. Patients and families sometimes find this hard to accept; the number looks alarming. The team is watching for bleeding and for the trend, and will explain their threshold if asked.

Most people on a dengue ward are not critically ill. They are being watched through a 24 to 48 hour window, per WHO, so that if the turn toward leakage comes, the response is minutes away rather than a taxi ride.

Why the dengue critical phase begins when the fever ends

Ask anyone who has nursed a child through dengue and they will describe the same confusing moment: the temperature normalizes, the child seems brighter for a few hours, and then something is off. Hands feel cool. The child is either unusually sleepy or oddly restless. This is the critical phase, and understanding it turns a frightening surprise into an expected checkpoint.

During the febrile days, the immune system mounts a response to the virus. As the virus is cleared and the fever falls, that response, in a minority of people, reaches its peak effect on the lining of small blood vessels. The vessels become porous for a limited period, most often 24 to 48 hours according to the WHO fact sheet. Plasma leaks, the platelet count reaches its low point, and the risk of shock and bleeding is highest. Then, as suddenly as it started, the leak seals, fluid returns to the bloodstream, and recovery begins.

Two practical consequences follow. The first is that the fever chart becomes a poor guide once the temperature drops. A clinician assessing dengue on the first afebrile day will barely glance at the thermometer and will instead look at the pulse, the blood pressure, the abdomen, the skin and the blood count. The second is that timing matters: a clinic review on day three of fever tells you little about what will happen on day five, which is why guidance pushes for review on the day the fever breaks and the day after.

Not everyone has a dramatic critical phase. The WHO notes that most infections are mild, and in those cases the fever simply fades into tiredness. The point of monitoring is not to expect the worst but to make sure that, for the minority in whom the leak is significant, no one is at home guessing.

Platelets, hematocrit and the tests that guide dengue care

Dengue is one of the few common illnesses in which patients routinely quote their own lab values, and one of the few in which those values can genuinely mislead. Two numbers dominate: the platelet count and the hematocrit. A third set of tests confirms the diagnosis.

Platelets are the small fragments in blood that plug leaks in vessel walls. In dengue the count falls, sometimes steeply, reaching its lowest point around the critical phase and then recovering on its own within days. A low count is expected; what alarms clinicians is a count that is falling fast at the same time the hematocrit is rising, because that pairing points to active plasma leakage. A low but stable count in someone who is drinking well, urinating and not bleeding is far less worrying than the raw number suggests.

Hematocrit is the proportion of blood volume occupied by red cells. It is the more informative test for judging leakage because it moves in near real time with plasma volume. The CDC’s clinical guidance describes a rise of 20 percent or more from the person’s own baseline as a sign of hemoconcentration. This is why a single blood test is less useful than two taken a day apart: the trend tells the story.

Diagnostic tests come in two kinds, per CDC guidance. Early in the illness, laboratories look for the virus itself, using a molecular test called PCR or a test for a viral protein called NS1 antigen. From about the end of the first week, antibody tests for IgM, the early-response antibody, become more reliable. Which test is chosen depends on how many days someone has been ill.

None of these tests, on its own, decides admission. They are read alongside the person in the chair: how they look, whether they can drink, what the abdomen feels like. Numbers guide; clinicians decide.

How long are you hospitalized for dengue? What the following days usually look like

There is no fixed length of stay for dengue, and any figure quoted as standard should be treated with suspicion. What guidance does describe is the shape of the illness, and the shape sets the timeline.

The WHO fact sheet gives a febrile phase of 2 to 7 days and a critical phase that most often spans 24 to 48 hours after the fever settles. A ward admission for warning signs usually aims to cover that critical window and the first day or so of recovery, when the team confirms that the hematocrit is falling back toward normal, urine output is steady, the person is eating and drinking, and the platelet count has stopped dropping and begun to climb. Common discharge criteria in WHO guidance include being free of fever for at least 24 hours without fever medicine, a return of appetite, stable vital signs, no breathing difficulty, and a rising platelet trend. When those are met, people go home; the calendar does not decide.

Someone admitted with established severe dengue and shock stays longer, because the team needs to see organ function recover and be certain the fluid given during the leak has been safely cleared. That duration is set case by case.

The recovery phase at home brings its own surprises. Many people develop a second rash, sometimes intensely itchy, with pale islands in a red background. Profound fatigue is common and can outlast the rash by days or, in some people, weeks, per Mayo Clinic and NHS descriptions of recovery. Appetite returns before energy does. Bruising may appear from earlier low platelets. None of these require readmission, but a follow-up blood count is often arranged to confirm the platelets have normalized.

Repeat mosquito protection matters during recovery, too. For roughly the first week of illness, a person with dengue can pass the virus to a biting mosquito, which can then infect others in the household.

Which medicines help in dengue, and which are avoided

Dengue has no specific antiviral treatment, a fact stated plainly by the WHO, CDC, NHS and Mayo Clinic. That absence shapes everything about the medicine cabinet, and it is worth understanding what the few drugs involved actually do.

Acetaminophen, the generic name for the most common over-the-counter fever and pain reliever, lowers temperature by acting on the brain’s heat-regulating centre and eases headache and body aches. It does not affect platelets, which is why it is the recommended option. It is processed by the liver, and dengue itself can stress the liver, so clinicians will advise on how to use it and may check liver tests in hospital. Any question about amount or frequency belongs with the prescriber or pharmacist.

Aspirin and non-steroidal anti-inflammatory drugs, a class that includes ibuprofen and naproxen, are avoided. They reduce the ability of platelets to stick together and can irritate the stomach lining, both of which raise bleeding risk when platelets are already low. The CDC’s patient guidance is explicit on this point. People who take a low-dose aspirin or an anticoagulant for a heart or clot condition should not stop it on their own; the treating team weighs that decision.

Antibiotics have no role unless a separate bacterial infection is identified, because dengue is viral. Steroids have been studied and are not recommended in routine dengue care by WHO guidance. Intravenous fluids are, in practical terms, the main “medicine” of the ward, and the choice of fluid and its rate are clinical decisions made against the hematocrit and vital signs.

Herbal preparations sold as platelet boosters have not been shown in high-quality trials to change outcomes, and none appears in WHO or CDC guidance. The next section takes that belief apart in more detail.

What people often get wrong about dengue care

Dengue attracts folklore the way standing water attracts mosquitoes. Some of these beliefs are harmless; a few can delay care or cause harm. Here are the ones clinicians hear most.

“The fever is gone, so the danger is over.” The reverse is closer to the truth. WHO guidance places the highest-risk window in the 24 to 48 hours after the fever settles. A normal thermometer reading on day four is a reason for a check-up, not a reason to skip one.

“Low platelets mean I need a transfusion.” Platelet transfusion is reserved for significant bleeding in WHO and CDC guidance, not for a number on its own. Counts recover spontaneously as the illness passes, and transfused platelets do not last in dengue.

“Papaya leaf or some other remedy raises platelets.” Small studies exist, but no major guideline endorses any herbal preparation, and none has been shown in robust trials to prevent severe dengue. Time spent chasing a remedy is time not spent on fluids and follow-up.

“Antibiotics will speed this up.” Dengue is a virus. Antibiotics do nothing against it and can add side effects.

“Ibuprofen is fine for the aches.” NSAIDs and aspirin are avoided in dengue because of bleeding risk, per CDC guidance. Acetaminophen is the fever reducer clinicians recommend, used as directed.

“Once you have had dengue, you are immune.” Infection gives lasting protection only against that one serotype. WHO and CDC both note that a second infection with a different serotype carries a higher risk of severe disease, which is why prevention matters after recovery, not less.

“Hospital is always safer.” For a low-risk adult with no warning signs, structured home care with daily review is what guidelines recommend, and a ward bed adds little. The safest place is the one where monitoring actually happens.

Questions to ask your care team about dengue treatment

People remember perhaps a third of what is said in a clinic visit, and dengue visits are short and repeated. Bringing a written list turns a rushed review into a conversation. These questions are drawn from what patients most often wish they had asked.

• Which group am I in today, and what would move me from home care to admission?
• When exactly should I come back, and what do you want to check at that visit?
• How much should I be drinking, and how will I know it is enough?
• Which fever medicine should I use, how should I take it, and which should I avoid?
• I take a daily blood thinner or aspirin for another condition. What should I do about it during dengue?
• What day of illness am I on, and when do you expect the fever to break?
• What is my platelet count and hematocrit today, and what trend would concern you?
• If I am admitted, what will the fluids and monitoring involve, and what would tell you I am ready to go home?
• Which warning signs should make me come straight back, even at night, and where should I go?
• Is anyone else in my household at risk, and how do we stop mosquitoes biting me while I am still infectious?
• After recovery, do I need a follow-up blood test, and when can I return to work or school?

Notice that several of these questions are about numbers and trends rather than reassurance. Clinicians generally appreciate a patient who wants to understand the hematocrit rather than one who simply wants to hear “you’re fine.” The answers also help family members share the watching. A partner who knows that persistent vomiting or a swollen, tender abdomen means an immediate return visit is a genuine part of the safety net that guidelines assume exists at home.

When to call your doctor: red-flag signs in dengue

Seek care the same day, or go to an emergency department, if any of these appear during dengue, especially in the day or two after the fever settles. These are the warning signs and severe features listed by the CDC and WHO, and they mean the plan needs to change now, not at the next scheduled review.

• Severe or persistent abdominal pain, or an abdomen that is tender or swollen.
• Vomiting that will not stop; the CDC uses three or more times in 24 hours as a marker.
• Bleeding from the nose or gums, blood in vomit or stool, black stools, or heavy menstrual bleeding.
• Unusual drowsiness, confusion, restlessness or irritability, or fainting.
• Cold, clammy or pale skin, especially hands and feet.
• Rapid or difficult breathing.
• Passing very little urine, or none for six hours or more.
• Inability to keep fluids down, in a child or an adult.

For infants, pregnant women, older adults and anyone with diabetes, kidney disease, heart disease or a bleeding disorder, the threshold for calling is lower, and a clinician may ask to see you daily regardless of how you feel.

Call your regular doctor or clinic, rather than the emergency department, for questions about fever control, how much to drink, itching in the recovery phase, or when to schedule the next blood test. If in doubt about which category a symptom falls into, treat it as urgent. Dengue rewards early action and punishes waiting, and no clinician will fault a family for coming back to be checked on the first afebrile day.

Every decision about admission, fluids, transfusion and discharge belongs to the treating team, who can see the trends in the person in front of them. This article can explain what those decisions weigh; it cannot make them.

Recovering after dengue and lowering the risk of a second infection

The last thermometer reading is not the end of the story. The recovery phase has a texture of its own, and it is also the moment when prevention matters most, because the next infection is the one that carries higher risk.

Fatigue is the dominant complaint. Mayo Clinic and NHS descriptions of dengue both note that tiredness can persist well after other symptoms fade, and many people describe a heaviness that lasts days to a few weeks. A gradual return to activity, with rest when the body asks for it, is the usual advice. The itchy convalescent rash is a sign of healing vessels, not a new problem, and it resolves without treatment. Bruises from the low-platelet days fade as the count recovers, and a follow-up blood test, if your team requests one, will usually confirm that.

Mosquito protection during and after illness is not only self-protection. A person with dengue carries virus in the blood for roughly the first week and can infect an Aedes mosquito that bites them, according to CDC and WHO, so sleeping under a net and using repellent while ill shields the household. Longer term, the same measures apply: repellents containing recognized active ingredients, long sleeves at dawn and dusk when Aedes feeds, screens on windows, and emptying the saucers, buckets and tyres where the mosquito breeds.

Immunity after dengue is serotype-specific. The WHO explains that recovery gives lasting protection against the serotype that caused the illness but only brief protection against the other three, and that a second infection with a different serotype carries a higher risk of severe dengue. That is the evidence-based reason to take prevention seriously after recovery rather than relaxing it. Vaccines exist for some populations and settings; whether one is appropriate is a conversation for your clinician, and no vaccine replaces bite prevention.

Frequently asked questions

Should you go to the hospital for dengue?

Not everyone with dengue needs a hospital, but everyone needs a clinical assessment and a plan for daily review. Most healthy adults and older children without warning signs are managed at home with fluids, rest and repeat blood counts. Admission is usually advised for warning signs such as persistent vomiting, abdominal pain, bleeding or drowsiness, for pregnancy, infancy, older age or chronic illness, and when someone cannot drink enough or has no one at home to watch them.

Which hospital is best for dengue?

There is no single best hospital for dengue, and choosing one is rarely the decision that matters. Dengue care is supportive and follows the same WHO and CDC guidance everywhere: fluids, monitoring of vital signs and blood counts, and prompt response to warning signs. The most useful facility is the one you can reach quickly if your condition changes overnight. Your regular clinician or local emergency service is the right place to start, and they can refer onward if needed.

Does dengue go away completely?

Yes, in the great majority of cases dengue resolves fully with supportive care, and the WHO notes that most infections are mild or without symptoms. There is no antiviral that removes the virus faster; the body clears it, and treatment supports the circulation through the critical phase. Fatigue can linger for a few weeks. Severe dengue can be life-threatening, which is why monitoring exists, but with timely care most people who develop it also recover.

How long are you hospitalized for dengue?

There is no set length of stay. A ward admission for warning signs typically covers the critical phase, which the WHO describes as most often lasting 24 to 48 hours after the fever settles, plus the first day or so of recovery until vital signs are stable, urine output is normal, appetite returns and platelets are rising. Severe dengue with shock requires a longer stay set by the treating team. Discharge follows clinical criteria, not a calendar.

What are the dengue warning signs I should watch for at home?

The WHO and CDC list severe abdominal pain or tenderness, persistent vomiting, bleeding from the nose or gums or in vomit or stool, unusual drowsiness or restlessness, rapid breathing, a swollen abdomen and, on blood tests, a rising hematocrit with falling platelets. These most often appear in the day or two after the fever drops. Any one of them means returning to care immediately rather than waiting for the next scheduled visit.

What is the dengue critical phase and when does it happen?

The critical phase is the period when small blood vessels can become leaky, allowing plasma to escape and blood pressure to fall. According to the WHO it usually begins as the fever settles and lasts around 24 to 48 hours. Not everyone has a noticeable critical phase; for many the fever simply fades into tiredness. Clinicians focus reviews on this window because it is when warning signs and shock are most likely to develop.

Can I have dengue without a fever?

Yes. The WHO notes that many dengue infections cause no symptoms or only mild ones, and fever in those who do get sick lasts 2 to 7 days before dropping. A normal thermometer reading during the illness does not rule dengue out and, once the fever has gone, does not mean the risk has passed. If you have other symptoms after a possible exposure, a clinician can order the appropriate blood test based on how many days you have been unwell.

What does outpatient dengue management involve?

Outpatient care means rest, plenty of oral fluids such as water, oral rehydration solution and soups, fever control with acetaminophen as directed, avoiding aspirin and NSAIDs, and returning for daily or near-daily review with a blood count, especially on the day the fever breaks and the day after. Someone at home should watch for warning signs. It is a conditional plan: if vomiting, abdominal pain, bleeding or drowsiness appear, care moves to the hospital.

Why are aspirin and ibuprofen avoided in dengue?

Both interfere with how platelets stick together, and aspirin and NSAIDs such as ibuprofen can also irritate the stomach lining. In dengue the platelet count is already falling and vessels are fragile, so these drugs add bleeding risk, which is why CDC guidance advises against them. Acetaminophen does not affect platelets and is the recommended fever reducer. Anyone taking aspirin or a blood thinner for another condition should ask their clinician rather than stopping it alone.

Do low platelets in dengue always need a transfusion?

No. WHO and CDC guidance reserves platelet transfusion for significant bleeding, not for a low count on its own. Platelets fall predictably in dengue, reach their lowest around the critical phase and recover without treatment as the illness passes. Transfused platelets are consumed quickly in dengue and carry risks of their own. Clinicians watch for bleeding and for the trend in hematocrit and platelets together, and will explain their threshold if you ask.

References

• WHO: Dengue and severe dengue fact sheet
• CDC: Treatment of dengue
• CDC: Clinical care of dengue (for healthcare providers)
• NHS: Dengue

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.